Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry
- DOI
- 10.1038/s41375-026-03024-y
- Published
- 2026-07-17
- Container
- Leukemia
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-026-03024-y,
title = {Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry},
author = {Maël Heiblig and Zofia Gross and Amine Belhabri and Urbain Tauveron-Jalenques and Emmanuelle Tavernier and Gaspar Requena Aspas and Martin Carré and Adrien Contejean and Nadine Boullanger Fow Heng and Clémence Santana and Clément Rocher and Sylvain Lamure and Gian-Matteo Pica and Mauricette Michallet and Jérôme Cornillon and Mathieu Meunier and Natacha Mauz and Samy Chraibi and Ugo Thevenet and Arthur Dony and Grégoire Le Meur and Lucie Coster and Sylvie Tondeur and Emmanuel Beillard and Serge Carillo and Delphine Manzoni and Pascale Flandrin and Thomas Tassin and Sarah Huet and Adriana Plesa and Unknown and Guieze Romain and Aspas Requena Gaspar and Fayard Amandine and Ravinet Aurélie and Abdo Chrystelle and Abitayeh Rami and Balsat Marie and Baroudi Nboureddine and Barraco Fiorenza and Beillard Emmanuel and Belhabri Amine and Cacheux Victoria and Carre Martin and Chevalier Simon and Contejean Adrien and Cornillon Jérome and Dony Arthur and Doublet Charlotte and Ducastelle-Lepretre Sophie and Duprat Manon and Faure Anne Camille and Flandrin-Gresta Pascale and Fossard Gaelle and Gilis Lila and Girard Sandrine and Grange Béatrice and Hacini Maya and Hayette Sandrine and Huet Sarah and Jacob Marie Christine and Labussière-Wallet Hélène and Lachenal Florence and Lefebvre Christine and Legrand Clémentin and Lours Camille and Loron Sandrine and Manzoni Delphine and Mauz Natacha and Meunier Mathieu and Michallet Mauricette and Moluçon-Chabrot Cécile and Virelizier Emmenuelle-Nicolas and Noyel Pauline and Park Sophie and Parry Anne and Raskovalova Tatiana and Rigollet Lauren and Rocher Clément and Sujobert Pierre and Santana Clémence and Tardy Stéphanie and Tavernier Emmanuelle and Thiebaut Francoise and Thiebaut-Bertrand Anne and Tigaud Isabelle and Tondeur Sylvie and Gire Marion and Joassard Anaelle and Jaillard Lucie and Coster Lucie and Tauveron-Jalenques Urbain and Grimaud Yoann and Plesa Adriana and Lamure Sylvain and Fatrara Thomas},
year = {2026},
journal = {Leukemia},
doi = {10.1038/s41375-026-03024-y},
url = {https://doi.org/10.1038/s41375-026-03024-y}
}RIS
TY - JOUR TI - Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry AU - Maël Heiblig AU - Zofia Gross AU - Amine Belhabri AU - Urbain Tauveron-Jalenques AU - Emmanuelle Tavernier AU - Gaspar Requena Aspas AU - Martin Carré AU - Adrien Contejean AU - Nadine Boullanger Fow Heng AU - Clémence Santana AU - Clément Rocher AU - Sylvain Lamure AU - Gian-Matteo Pica AU - Mauricette Michallet AU - Jérôme Cornillon AU - Mathieu Meunier AU - Natacha Mauz AU - Samy Chraibi AU - Ugo Thevenet AU - Arthur Dony AU - Grégoire Le Meur AU - Lucie Coster AU - Sylvie Tondeur AU - Emmanuel Beillard AU - Serge Carillo AU - Delphine Manzoni AU - Pascale Flandrin AU - Thomas Tassin AU - Sarah Huet AU - Adriana Plesa AU - Unknown AU - Guieze Romain AU - Aspas Requena Gaspar AU - Fayard Amandine AU - Ravinet Aurélie AU - Abdo Chrystelle AU - Abitayeh Rami AU - Balsat Marie AU - Baroudi Nboureddine AU - Barraco Fiorenza AU - Beillard Emmanuel AU - Belhabri Amine AU - Cacheux Victoria AU - Carre Martin AU - Chevalier Simon AU - Contejean Adrien AU - Cornillon Jérome AU - Dony Arthur AU - Doublet Charlotte AU - Ducastelle-Lepretre Sophie AU - Duprat Manon AU - Faure Anne Camille AU - Flandrin-Gresta Pascale AU - Fossard Gaelle AU - Gilis Lila AU - Girard Sandrine AU - Grange Béatrice AU - Hacini Maya AU - Hayette Sandrine AU - Huet Sarah AU - Jacob Marie Christine AU - Labussière-Wallet Hélène AU - Lachenal Florence AU - Lefebvre Christine AU - Legrand Clémentin AU - Lours Camille AU - Loron Sandrine AU - Manzoni Delphine AU - Mauz Natacha AU - Meunier Mathieu AU - Michallet Mauricette AU - Moluçon-Chabrot Cécile AU - Virelizier Emmenuelle-Nicolas AU - Noyel Pauline AU - Park Sophie AU - Parry Anne AU - Raskovalova Tatiana AU - Rigollet Lauren AU - Rocher Clément AU - Sujobert Pierre AU - Santana Clémence AU - Tardy Stéphanie AU - Tavernier Emmanuelle AU - Thiebaut Francoise AU - Thiebaut-Bertrand Anne AU - Tigaud Isabelle AU - Tondeur Sylvie AU - Gire Marion AU - Joassard Anaelle AU - Jaillard Lucie AU - Coster Lucie AU - Tauveron-Jalenques Urbain AU - Grimaud Yoann AU - Plesa Adriana AU - Lamure Sylvain AU - Fatrara Thomas PY - 2026 JO - Leukemia DO - 10.1038/s41375-026-03024-y UR - https://doi.org/10.1038/s41375-026-03024-y ER -
APA
Heiblig, M., Gross, Z., Belhabri, A., Tauveron-Jalenques, U., Tavernier, E., Aspas, G. R., Carré, M., Contejean, A., Heng, N. B. F., Santana, C., Rocher, C., Lamure, S., Pica, G., Michallet, M., Cornillon, J., Meunier, M., Mauz, N., Chraibi, S., Thevenet, U., Dony, A., Meur, G. L., Coster, L., Tondeur, S., Beillard, E., Carillo, S., Manzoni, D., Flandrin, P., Tassin, T., Huet, S., Plesa, A., Unknown, Romain, G., Gaspar, A. R., Amandine, F., Aurélie, R., Chrystelle, A., Rami, A., Marie, B., Nboureddine, B., Fiorenza, B., Emmanuel, B., Amine, B., Victoria, C., Martin, C., Simon, C., Adrien, C., Jérome, C., Arthur, D., Charlotte, D., Sophie, D., Manon, D., Camille, F. A., Pascale, F., Gaelle, F., Lila, G., Sandrine, G., Béatrice, G., Maya, H., Sandrine, H., Sarah, H., Christine, J. M., Hélène, L., Florence, L., Christine, L., Clémentin, L., Camille, L., Sandrine, L., Delphine, M., Natacha, M., Mathieu, M., Mauricette, M., Cécile, M., Emmenuelle-Nicolas, V., Pauline, N., Sophie, P., Anne, P., Tatiana, R., Lauren, R., Clément, R., Pierre, S., Clémence, S., Stéphanie, T., Emmanuelle, T., Francoise, T., Anne, T., Isabelle, T., Sylvie, T., Marion, G., Anaelle, J., Lucie, J., Lucie, C., Urbain, T., Yoann, G., Adriana, P., Sylvain, L., & Thomas, F. (2026). Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry. Leukemia. https://doi.org/10.1038/s41375-026-03024-y
Source records
- crossref · retrieved 2026-09-27T05:59:36.704Z